Mylène Perreault, PhD, is the Head of Research at Synlogic and is responsible for leading the nonclinical strategy and operations from program inception to clinical proof-of-mechanism for metabolic and immunology-related disorders. She is a PhD scientist with more than 20 years of experience in the pharmaceutical industry with extensive nonclinical pharmacology experience. In addition, she has led platform and drug discovery projects that have resulted in multiple investigational new drug (IND) approvals. Perreault earned a PhD in physiology-endocrinology and a BS in biology from Laval...Read more
